Tailwind Biotech ApS
CVR 43630938 · Private limited company (ApS) · Active · High risk
Tailwind Biotech ApS is a Private limited company (ApS), founded on , based in Taastrup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.8% over the next 12 months, which is 2.0 times the average for Danish companies. 3 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -32k and a net result of DKK -42k. CEO: Christopher Thomas Workman, Lorenzo Carvelli, Mirko Ceriani.
Bankruptcy risk for Tailwind Biotech ApS
2.0 × the average (1.41%) · higher risk than 87% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43630938
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- c/o L. Carvelli, Blåkildevej 9
2630 Taastrup - Municipality
- Høje-Taastrup
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Consens, Statsautoriseret Revisionsanpartsselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 3 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -135.6% |
| Current ratio | 42% |
| Moves (last 2 years) | 2 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 637k | DKK 853k | DKK 322k |
| Net profit | DKK -42k | DKK -27k | DKK -4,117 |
| Equity | DKK -32k | DKK 9,221 | DKK 36k |
| Total assets | DKK 24k | DKK 49k | DKK 68k |
| Cash | DKK 0 | DKK 28k | – |
| Short-term debt | DKK 56k | DKK 39k | – |
| Avg. employees | 0 | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Consens, Statsautoriseret Revisionsanpartsselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 122 | ||
| 1 Jan 2024 – 31 Dec 2024 | 99 | ||
| 1 Nov 2022 – 31 Dec 2023 | 85 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christopher Thomas Workman | Current | |
| CEO | Lorenzo Carvelli | Current | |
| CEO | Mirko Ceriani | Current | |
| Owner (25%) | CTW Holding ApS | Current | |
| Owner (10%) | HT Simonsen Holding ApS | Current | |
| Owner (25%) | LCAR Holding ApS | Current | |
| Owner (25%) | MC44 Holding ApS | Current | |
| Owner (15%) | HT Simonsen Holding ApS | ||
| Owner (20%) | KRRM Holding ApS | ||
| Owner (15%) | LCAR Holding ApS | ||
| Owner (15%) | MC44 Holding ApS | ||
| Founder | HT Simonsen Holding ApS | Current | |
| Founder | CTW Holding ApS | Current | |
| Founder | KRRM Holding ApS | Current | |
| Founder | LCAR Holding ApS | Current | |
| Founder | MC44 Holding ApS | Current |
The CEOs' other companies
Christopher Thomas Workman – 1 other companies
- CTW Holding ApS Active
Lorenzo Carvelli – 1 other companies
- LCAR Holding ApS Active
Mirko Ceriani – 1 other companies
- MC44 Holding ApS Active
Address history (2 moves)
| c/o L. Carvelli, Blåkildevej 9, 2630 Taastrup | |
| c/o L. Carvelli, Matthæusgade 50, 4. 31, 1666 København V | |
| Ørestads Boulevard 55A, 3. 301, 2300 København S |
Similar companies in Høje-Taastrup
- metaLead Therapeutics ApS Taastrup
- KEM-EN-TEC DEVELOPMENT & LICENSING A/S Taastrup
Questions and answers about Tailwind Biotech ApS
Has Tailwind Biotech ApS gone bankrupt?
No, Tailwind Biotech ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Tailwind Biotech ApS?
Our model estimates a bankruptcy risk of 2.8% over the next 12 months (high risk), which is 2.0 times the average for Danish companies.
Who is the CEO of Tailwind Biotech ApS?
Christopher Thomas Workman, Lorenzo Carvelli, Mirko Ceriani are the CEOs of Tailwind Biotech ApS.
Who is the auditor of Tailwind Biotech ApS?
Tailwind Biotech ApS most recently used Consens, Statsautoriseret Revisionsanpartsselskab.
When was Tailwind Biotech ApS founded?
Tailwind Biotech ApS was founded on 1 November 2022.
What is the equity of Tailwind Biotech ApS?
Equity was DKK -32k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.